Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,383 | -183,524 | -141,437 | -108,825 | -56,849 |
| Depreciation Amortization | 1,019 | 4,067 | 3,039 | 2,019 | 1,328 |
| Accounts receivable | -1,567 | -8,224 | 384 | 6,287 | 3,855 |
| Accounts payable and accrued liabilities | -10,758 | 1,887 | -3,072 | -1,911 | 9,533 |
| Other Working Capital | -4,691 | 3,864 | -816 | 5,092 | 13,815 |
| Other Operating Activity | 17,000 | 22,459 | 12,788 | 2,273 | -10,793 |
| Operating Cash Flow | $-38,380 | $-159,471 | $-129,114 | $-95,065 | $-39,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -207 | -39 | -26 | -21 |
| Purchase Sale Intangibles | -375 | -1,391 | -1,065 | -816 | -422 |
| Other Investing Activity | -375 | -1,391 | -1,065 | -816 | -422 |
| Investing Cash Flow | $-438 | $-1,598 | $-1,104 | $-842 | $-443 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 50,000 | 50,000 | 50,000 | 50,000 |
| Common Stock Issued | 150,949 | 31,975 | 272 | 166 | 72 |
| Other Financing Activity | -55,000 | -1,250 | -1,250 | -1,250 | -1,250 |
| Financing Cash Flow | $95,949 | $80,725 | $49,022 | $48,916 | $48,822 |
| Beginning Cash Position | 80,486 | 160,830 | 160,830 | 160,830 | 160,830 |
| End Cash Position | 137,617 | 80,486 | 79,634 | 113,839 | 170,098 |
| Net Cash Flow | $57,131 | $-80,344 | $-81,196 | $-46,991 | $9,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,380 | -159,471 | -129,114 | -95,065 | -39,111 |
| Capital Expenditure | -63 | -207 | -39 | -26 | -21 |
| Free Cash Flow | -38,443 | -159,678 | -129,153 | -95,091 | -39,132 |